Hideto Kameda

35PUBLICATIONS
67CO-AUTHORS
AutoimmunityPredictive and prognostic markersRheumatology and arthritisCancer therapy (excl. chemotherapy and radiation therapy)Molecular imaging (incl. electron microscopy and neutron diffraction)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Aug 04, 2026
Antigen-Specific Tolerization in Rheumatoid Arthritis: Evaluating the Translational Potential of hPAD4 Plasmid Therapy.

|Jun 26, 2026
Achievement of intermediate treatment targets for Still's disease under tocilizumab treatment: a post-hoc analysis of the phase III trial.

|May 12, 2026
Real-world effectiveness, safety and patient-reported outcomes of sarilumab in patients with rheumatoid arthritis: a 52-week, prospective, open-label, non-interventional, observational, nationwide, large-cohort study in Japan (PROFILE-J).

|Jan 29, 2026
Long-term safety and efficacy of tocilizumab in adult-onset Still's disease: open-label, long-term extension of the phase III trial.

Koji Suzuki, Hideto Kameda, Kei Ikeda

|Jan 28, 2026
Ultrasound evaluation of finger joint cartilage damage progression in patients with rheumatoid arthritis.

Takehisa Ogura, Chihiro Imaizumi, Ayako Hirata

|Jan 24, 2026
The prediction of a good therapeutic response and outcome: at baseline or after a short term?

Hideto Kameda, Reina Maezawa, Yasuto Minegishi

Pageof 6

Frequent Collaborators

11 joint publications

Yoshiya Tanaka

7 joint publications

Yuko Kaneko

6 joint publications

Tsutomu Takeuchi

5 joint publications

Kei Ikeda